1,804
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Community Engagement in Precision Medicine Research: Organizational Practices and Their Impacts for Equity

ORCID Icon, , , ORCID Icon, , & ORCID Icon show all

Abstract

Background

In the wake of mandates for biomedical research to increase participation by members of historically underrepresented populations, community engagement (CE) has emerged as a key intervention to help achieve this goal.

Methods

Using interviews, observations, and document analysis, we examine how stakeholders in precision medicine research understand and seek to put into practice ideas about who to engage, how engagement should be conducted, and what engagement is for.

Results

We find that ad hoc, opportunistic, and instrumental approaches to CE exacted significant consequences for the time and resources devoted to engagement and the ultimate impacts it has on research. Critical differences emerged when engagement and research decisionmaking were integrated with each other versus occurring in parallel, separate parts of the study organization, and whether community members had the ability to determine which issues would be brought to them for consideration or to revise or even veto proposals made upstream based on criteria that mattered to them. CE was understood to have a range of purposes, from instrumentally facilitating recruitment and data collection, to advancing community priorities and concerns, to furthering long-term investments in relationships with and changes in communities. These choices about who to engage, what engagement activities to support, how to solicit and integrate community input into the workflow of the study, and what CE was for were often conditioned upon preexisting perceptions and upstream decisions about study goals, competing priorities, and resource availability.

Conclusions

Upstream choices about CE and constraints of time and resources cascade into tradeoffs that often culminated in “pantomime community engagement.” This approach can create downstream costs when engagement is experienced as improvised and sporadic. Transformations are needed for CE to be seen as a necessary scientific investment and part of the scientific process.

Introduction

In recent decades, the field of precision medicine research (PMR), which studies the relationships among genes, behaviors, and environmental exposures, has been challenged by a lack of diversity in research participation (Need and Goldstein Citation2009; Popejoy and Fullerton Citation2016). In response, multiple initiatives now seek to include greater proportions of historically underrepresented populations in research. Community engagement (CE) has emerged as a key intervention to help achieve this goal, as well to acknowledge past harms in biomedical research and address persistent questions about trust and the conventional relationships that PMR researchers, and participants have with one another.

Our entry and contribution to debates about how to situate the invitation to underrepresented groups to participate in PMR within the broader social and political context and lived experiences of communities is an empirical one. Since 2018, we have followed how various PMR stakeholders responded to the call for greater diversity and inclusion: how they funded and designed studies, recruited populations, conducted data collection and analysis, and engaged diverse participants and communities. By empirically examining the range of perspectives, practices, and experiences of these activities, we aim to surface the normative assumptions, political dimensions, and social and ethical implications of implicit and overt choices made by PMR studies around CE practices.

In this paper, we examine how stakeholders approach three sets of questions: First, who to engage? That is, who is thought to represent the community? Second, what is CE, and how is it organized and conducted? And third, why engage communities; what is engagement for and what is it intended to produce? We find that ad hoc, opportunistic, and instrumental decisionmaking on who to engage, how community input is solicited and fits into study workflow, and what engagement was for had significant consequences for the time and resources devoted to CE and the ultimate impacts it has on research. These choices were also often contingent on previous, upstream decisions about research priorities and resources in ways that study personnel, in the moment, were frequently unable to discern. Such prior decisions cascaded into significant downstream consequences for what CE practices could achieve within the context of the PMR studies. In particular, we argue that the ways in which CE practices were implemented at times undermined the goals of inclusion and equity, potentially jeopardizing ongoing research relationships with communities and constraining the ability of PMR studies to provide equitable benefit. We end by offering reflections on the significance of these constraints for CE and their ramifications for relationships among researchers, research institutions, participants and communities.

Background

CE has been defined in many ways and covers a wide range of activities, as Tindana et al. (Citation2015, 1) suggest through their broad definition of CE as “a process of working collaboratively with a group or groups of people on a shared goal or common interest.” CE and its related terms (e.g., engagement of participants, stakeholders, publics, citizens, etc.) are frequently used interchangeably, and the purpose, strategies, processes, and outcomes of CE are often left ill-defined (Richardson et al. Citation2021). Many case studies of CE used in genomics and precision medicine research offer reflections on the ethical motivations, structures and practices, and lessons learned (Lemke et al. Citation2010; Lyles et al. Citation2018; O’Daniel et al. Citation2022; Tuttle et al. Citation2021). Some studies highlighted the impact of power imbalances for CE while conducting research in underserved communities. In their review of genomic research conducted in Africa, Tindana et al. (Citation2015; see also Agongo et al. Citation2021; Folayan, Oyedeji, and Fatusi Citation2015; Marsh et al. Citation2010) note that CE practices tended to support early phases of the research life course, such as participant recruitment. Brunger and Wall (Citation2016) underscore the critical consideration of “research fatigue,” defined as the experience of being asked the same questions without results being shared with the community, and the burden of being asked to engage in, approve, consult, and collaborate on research not directed at the needs of the community.

Multiple scholars (Cheung Citation2018; Dheensa et al. Citation2018; Moodley Citation2017; Sabatello and Appelbaum Citation2017; Tindana et al. Citation2017) critique biobanking efforts as extractive, especially against the backdrop of structural inequities in health and health research (see Lee Citation2021). This literature identifies a range of ethical issues including: benefits that are diffuse, overly promissory, and not equity-centered; informed consent issues that arise from data use that may occur at an unknown time in the future; and an increasing push to make data openly available, that tends to benefit researchers in the global North and wealthier institutions. Some biobanks have implemented CE efforts to navigate issues arising from increasing commercialization, including intellectual property and ownership of samples, data, and downstream products (Beaton et al. Citation2017; Burgess, O’Doherty, and Secko Citation2008; Cohn et al. Citation2015; Dry et al. Citation2017; O’Daniel et al. Citation2012).

An important thread underscored in CE scholarship is that it requires a clear warrant for research to be accountable. Pratt and de Vries (Citation2018) argue that the absence of an ethical obligation and philosophical rationale for CE leads funders to view CE as “good practice” but stop short of mandating or providing sufficient resources for it. Molyneux and Bull (Citation2013) identify “instrumental” goals such as increasing buy-in and enrollment, but note these can conflict with “intrinsic” goals of enacting inclusion and demonstrating respect. Finally, CE goals may invoke “transformative” aims to address power differentials and marginalization in current practices of scientific knowledge production (see also Gichuru et al. Citation2018; Reynolds and Sariola Citation2018; Versfeld et al. Citation2018). Key et al.’s (Citation2019) model of CE integrates health equity indicators (e.g., power and control, mutual benefit) and contextual factors (e.g., history, trust). Pratt and de Vries (Citation2018) assert that “shared health governance” should be a goal for global health research in low-and middle-income countries that aims to address health inequities, while Pratt, Yeong Cheah, and Marsh (Citation2020) argue for “solidarity.”

A handful of scholars have developed typologies of CE practices, paying particular attention to varying levels of engagement and their effects on both research and community relationships. Seeley, Kengeya-Kayondo, and Mulder (Citation1992), for example, proposed that CE occurs along a contract/consultative/collaborative spectrum, while Tindana et al. (Citation2015) further elaborated this into a typology based on whether approaches inform, consult, involve, collaborate, or empower.

Other models for conducting CE are often designed to materially express specific values like transparency and trust (Grayson, Doerr, and Yu Citation2020) and change prevailing practices (Sanders Thompson et al. Citation2021). These frameworks address common critiques that participation in and methods of CE are not truly democratic, and offer alternative practices that emphasize co-ownership, co-creation, and engagement at every research stage (Moodley and Beyer Citation2019; Murtagh et al. Citation2017; Wilson, Hall Jackson, and Harrell Citation2019). Reynolds and Sariola (Citation2018) argue that inclusive and meaningful CE must occur throughout all stages of knowledge production process, build skills and capacity of all parties, and aim to redress historical inequalities in North–South collaborations. Finally, Wilkins and Alberti (Citation2019, 6) point to needed changes in the politics of knowledge: “A substantial barrier to community engagement is the traditional way that knowledge is accepted as legitimate in the academy—that is, it must be disciplinary, expert led, hierarchical, and university based.” In response to ongoing concerns, several institutional models have been developed to facilitate community-engaged research in genomics and PMR (e.g., Blacksher et al. Citation2021; Fohner, Volk, and Woodahl Citation2019).

Despite much attention to CE in genomics research, we identified only one study that examined engagement practices across multiple studies. Haldeman et al. (Citation2014) examined CE among six US-based biobank sites and identified variability in definitions of “community,” CE practices, and reasons why biobanks undertake CE. No studies to our knowledge have combined an examination of different CE approaches with a comparative analysis of their effects, across the life course of the research studies, particularly those mandated to increase diversity and inclusion of underrepresented populations. However, the existing literature underscores the high stakes of how CE is implemented and practiced for whether it produces meaningful collaborations, community-research partnerships, and shared benefits, or whether it is seen as instrumental, transactional, and hierarchical ‘science as usual.’ Our data help to fill this gap, by uncovering the upstream-downstream dependencies that shape who, when, how, and with what effects CE is conducted, and how prior decisions about research goals and resources facilitate or constrain different kinds of CE practices. These practices in turn exact consequences for the relationships connecting communities, participants, researchers, and research institutions, and their potential to promote or hinder equity and inclusion.

Methods

This paper is part of a larger project investigating how diversity and inclusion are interpreted and operationalized in PMR studies, and impact practices such as enrollment, retention, engagement, data collection and analysis, and return of results. We followed five PMR studies across three consortia funded by the US National Institutes of Health (NIH). These five studies were selected because they were located in geographically diverse areas and used heterogeneous strategies to engage, recruit, and retain underrepresented individuals as research participants. Institutional review board approval was obtained from the University of California, San Francisco and Columbia University.

Our sources of data include: a content analysis of 76 documents, including study materials and funding announcements issued by the NIH; approximately 450 h of observations of study activities, including site and consortium working group calls, and in-person or virtual meetings; and 125 in-depth interviews. Interviews included 102 initial and 23 follow-up interviews, each lasting 60-90 min, with a purposive sample that included funders of PMR research (n = 4), PMR investigators (n = 30), research team members (n = 64), and research participants/participant advisory board members (n = 4) (see for aggregate demographic characteristics). Interviewees were purposively recruited based on their involvement in our five study sites or the PMR consortia to which they belonged. Semi-structured interviews explored the engagement, recruitment, and retention of underrepresented participants, as well as how study teams were operationalizing diversity mandates in their research. Interview guides were tailored, to enable us to ask about roles and activities relevant for each participant. Interviewees were offered a $50 gift card for each interview. All interviews were recorded and professionally transcribed verbatim.

Table 1. Interview sample characteristics.

All data, including documents, observation fieldnotes, and interview transcripts, were analyzed using the principles of constructivist grounded theory (Charmaz Citation2014). Consistent with this methodology, we treated documents, observation fieldnotes, and interviews all as raw data and analyzed them as one comprehensive dataset: we did not triangulate among different data sources, although we did use information gathered from one source to inform other data collection (e.g., crafting interview questions based on observations). The research team generated an initial codebook based on study aims, the existing literature, and issues that emerged repeatedly during data collection. Using the qualitative analysis software, Dedoose, the research team coded a small sample of documents, interview transcripts, and observation fieldnotes with this initial codebook; additional codes that arose through our inductive examination of the data were then included in the codebook. Through consecutive waves of independent and joint coding, followed by discussion and reconciliation, we finalized a codebook of 75 codes (some of which also have 2-14 sub-codes). For this analysis, we extracted a subset of data tagged with specific codes related to participant and CE; we then engaged in multiple (at least two) rounds of review and extensive memoing on these data, by different team members to allow for variable and iterative analysis and interpretation. Emerging interpretations and patterns with supporting data were iteratively presented to the whole research team and discussed and refined, leading to the generation of categories of codes and themes that led to this paper’s findings.

Results

Our data illustrate wide-ranging perspectives on who is thought to represent the community, how CE is implemented, and what CE is for and what the goals of CE ought to be. We did not discern any systematic differences by stakeholder type or group, but instead observed a range of views within each group. Below we discuss these views and provide illustrative data and quotes in .

Table 2. Perspectives on who represents the ‘community’.

Table 3. Perspectives on how to engage communities.

Table 4. Perspectives on what community engagement is for.

Table 5. Experiences of “pantomime community engagement”.

Who is the ‘community’? Targeted versus ad hoc outreach

Interviewees had varied perspectives on who best to include as community representatives (). They often described the importance of working with community insiders to open doors for them and broker relationships, and sought to engage communities through “trusted messengers.” However, in practice, many researchers reported using fairly ad hoc, opportunistic ways of tapping individuals for community input, based on convenience and networks of community members already known to them (as illustrated in 2 A).

When researchers described other strategies for selecting community members to engage with, they often weighed such criteria as personal characteristics, preexisting relationships with the research institution, connections to communities, bandwidth to take on collaborations, and previous experience with biomedical research. Valuing such criteria for choosing community advisors often meant that they were enthusiasts of research and had experience navigating and interacting with research and healthcare institutions (2B).

Such practices—where community representatives were selected in ad hoc fashion, and criteria for engagement included those who had existing, positive relationships with the researchers or the research institution, and were willing and available to be involved—underscore that decisions about who to engage impact the outcomes of engagement. Relying on such community advisors, rather than a broader group of others who may not be as aligned or involved with the research community, likely yields different feedback (2C). When the intent is to engage communities who are underrepresented in research, the practices of soliciting community input from preexisting connections and willing brokers, and those with the availability and ability to partner with research institutions, problematize who, and in turn what concerns, are included and heard, or excluded and rendered invisible.

How should community engagement be done? The importance of the organizational chart and workflow

Researchers and funders understood it was crucial to embed engagement expectations and activities into the study process, and then consistently and actively support them. However, in general, their awareness of the need to embed CE into the conduct of studies did not consistently result in institutionalized practices. We found a great deal of diffuseness around what exactly constitutes engagement. Across the studies we followed, CE included distributing materials about their studies at community meetings, senior breakfasts, and neighborhood fairs. CE also included giving presentations at churches, barbershops, libraries, and businesses, and sharing information in neighborhood publications and media outlets. As one participant put it, “pretty much we try to go anywhere, anywhere that we can get the word out.”

Organizational nodes and activity streams in which CE occurs, and how work and decisionmaking authority flows through or around them, were influential in determining its impacts on research (). This included whether community members could determine which issues they considered, based on their own criteria, and revise or even veto proposals made upstream. The proximity or distance between where CE occurred and where research decisions were made was also highly consequential: the organizational structure of a study both reflected and reproduced explicit and implicit choices about whether and how community input should impact its conduct. One study was organized such that workflow must pass through community advisors, whose approval was required for research to proceed (3 A). In contrast, other studies had hub-and-spoke or parallel track models for community input, where research staff reached out for feedback, but the workflow did not necessarily require that such input be collected and addressed before moving forward (3B).

Other key aspects of how CE was implemented revolved around whether community members were recognized as experts, and how this was communicated (3 C). Relatedly, community advisors often did not know what happened to their feedback, whether it was explicitly considered in decisionmaking, and what impact their involvement had for how the study was conducted. For their part, researchers also often struggled to recall how their studies used the community input that had been collected, and the examples of study changes they gave were relatively minor and proscribed (3D). Thus a final point of emphasis in the conduct of CE was the importance of accountability to the community, and whether their input was built into and impacted how studies were conducted (3E). Everyday decisions and the minutiae of study implementation both reflected and shaped where power was located in the organization, workflow, and decisionmaking processes, and whether those study infrastructures allowed for collaboration and partnership, or continued hierarchy.

What is community engagement for?

Researchers and funders gave variable and sometimes contradictory responses to questions about the purpose and ultimate impact of CE (). In many instances, we noted that CE was invoked in the context of facilitating research, fostering study “awareness,” doing “outreach,” and recruitment and retention of participants (4 A) (see also Jeske et al. Citation2022). Such understandings of the nature and goals of CE gave it a transactional cast (4B), that it was a set of instrumental activities that could be quantified and measured by the number of individuals “touched” and recruited. These assessments of what constituted ‘successful’ CE were encapsulated in what one research team member referred to as the “bean counting” nature of engagement.

In contrast, other participants, often (but not only) those involved in community-based studies, conceptualized CE in broader terms, focusing instead on how it might fundamentally embed community priorities and concerns in the research. One way in which some of our interviewees interpreted the imperative to translate research findings with and for communities was a focus on how study findings in the form of interventions and programs would fuel health related changes (4 C). Others emphasized an even more transformational move—one that is well known to those who do community-based participatory or community-engaged research—that involves shifting what scientific questions guide research and who gets to decide (4D).

Finally, a third way some researchers and funders understood the purpose of CE was as long-term investments in relationships with and changes in communities (4E). In these conceptions, our interviewees emphasized that the return, rather than being measured in near-term (and easily quantifiable) increases in recruitment or even translations of study findings into better community health, may only be apparent years after an individual study has concluded. Given this, multiple interviewees expressed frustration with the limitations of the grant-funded model for CE in PMR, in which researchers cultivated community connections that served their purpose for one grant, but could not be sustained across studies.

“Pantomime community engagement”

How research teams made choices about who to engage, what engagement activities to support, how to solicit and integrate community input and/or decisionmaking into the workflow of the study, and what CE was for had significant consequences for the time and resources devoted to CE. Indeed, these choices were often conditioned upon upstream perceptions and decisions about study goals, competing priorities, and resource availability. We tracked, across many of the studies we followed, how constrained time and resources cascaded into tradeoffs that culminated in what one participant called “pantomime community engagement,” that is, performative practices that imitated CE ().

Many participants expressed frustration with the lack of time and funding to properly prepare and conduct engagement activities before the press of recruitment, enrollment, and data collection all begin. Almost all research staff we spoke to said that they were not sufficiently funded to undertake CE activities in meaningful or fulsome ways (5 A). Investigators talked about tough decisions when teams needed to cut budgets, often resulting in CE and diversity-related objectives being curtailed because, simply put, such activities were expensive and did not count as budgetary priorities because they were not seen as part of the science (5B).

The overall effect of this lack of time and funding to do CE is that many were not conducting what even their own staff would regard as purposeful CE. Instead, our interviewees spoke of a kind of ‘check box’ attitude where studies considered CE to be complete once certain tasks (e.g., meeting with community members, getting feedback on some study aspect or materials) had been checked off rather than when the underlying goal of more deeply engaging communities was achieved (5 C). At times, capitalizing on the ambiguity and variability of what constituted engagement described above, activities were retroactively labeled as being CE when they were not originally conceived as such. Participants understood such actions to stem from a belated recognition of the importance of CE and the perceived need to demonstrate that CE was being done, when it had not been intentionally planned or resourced. Some of our interviewees were deeply concerned about the potentially serious consequences when studies do not or feel unable to invest in cultivating long-term relationships with communities and conducting research that benefits them. As one research staff member put it: “That’s the covenant between participants and researchers, and we have to fulfill our promise or else, what are we even doing? … Why bother?” Otherwise, she warned, “it is one giant data grab. It is any possible data that could be gathered from a human being, all of those data, every single piece of data that can be gotten. All of it.”

Discussion: time, equity, and trust

Cumulatively, the sense of urgency, insufficient funds, the priority accorded to preserving “the science,” and the subsequent ways that engagement was done in improvised, sporadic ways, all exact downstream costs. Those involved in PMR frequently experienced CE and the research itself as two separate tracks that competed for resources and often could not be coordinated in a sequence that made sense: the research could not, or would not, wait for the engagement. Not only did “the science” dictate the pace that engagement efforts must follow, but structures and practices were not in place to enable engagement to impact the science. Under these conditions, CE may in fact lead to harms, as Brunger and Wall (Citation2016, 1870) note: “for communities feeling the effects of research fatigue, the ‘good’ of community engagement may lead to harms to overstretched and under-resourced communities; community engagement takes work.” We therefore note three takeaways from our study:

Commitment to CE requires new temporal expectations: Changing the temporal constraints on funding was seen as especially key. Research staff talked about building in engagement before the study and continuing it after its conclusion. Others spoke of the necessity of investing in sustainability beyond single studies, making “longitudinal goals” and “historical investments” with respect to CE. These experiences echo the guidance offered by many CE scholars: Wilkins and Alberti (Citation2019, 6), for example, argue that research funding should “specifically include opportunities for community engagement, allow expenditures that are aligned with community partners’ needs and expertise.” However, a fair number of our participants sense that science is proceeding as usual, while, as one put it, community researchers “go their own pathway, trying to use duct tape and string, to get access to resources and … create science that’s meaningful to their community.”

CE to achieve inclusion and equity requires rethinking altruism and benefit: Our findings interrogate the current ethical paradigm for thinking about research participation as acts of altruism in a voluntary gesture without expectation of direct tangible benefits (Lee Citation2021). That is, while research may have societal and downstream benefits to future individuals, participants themselves will likely not benefit, and this understanding has structured and shaped ideas about fairness and reciprocity between researchers and participants. However, goals of diversity and inclusion of underrepresented communities call into question whether this framework is sufficient. Instead, the research relationship—and research itself—require reconsideration.

Research infrastructures must be rebuilt, not to promote efficiency, but to support meaningful research relationships: One alternate approach is to give up efficiency in return for deep engagement, reflecting an altogether different politics of knowledge—not science as usual, but research practices premised on equity and shared power and decisionmaking, among community members, other stakeholders, and scientists. This is the spirit in which Wilson, Hall Jackson, and Harrell (Citation2019, 94) call for “authentic relationship with the community” that demands “listening, observing, and participating in the community in such a way that we can understand and articulate its needs, allowing those needs to shape the research agenda.”

In a similar vein, Adams, Burke, and Whitmarsh (Citation2014, 180; see also Alleva Citation2006; Müller Citation2014) open a conversation about “slow research” and what kind of science might serve global health goals:

We are all being asked to be productive in ways that create a sense of having to do more and to do it faster … These demands are not simply a result of how we conceptualize efficiency or capacity. Rather, they are directly related to problems of funding (capital), globalization (scale), and quality and focus (method). A call for slow research interrogates these demands. Slow research is not about doing less over time, although there is a temporal concern … It entails working with an ethic or set of values and strategies that valorize different things from the emergent norms. Slow research calls for a deliberate shift in the way we do our work and the ways in which that work and its products are valorized.

In these conceptualizations, research starts with the local—being there together with communities, the importance of the particular and specific details and histories of places and peoples. This attention to the local is also in relationship to knowledge, such that we understand knowledge to be situated in, produced by, and make sense within the local context. Slow research also asks that we resist the celebration of speed and efficiency and utility, so that we might see the benefits of extended time, long relationships, and deep understanding. Citing the time and resource intensive nature of CE, Pratt and de Vries (Citation2018) acknowledge this as potentially having “the perverse effect of slowing research or preventing otherwise worthwhile studies from being conducted”; however, they emphasize that such attention to the process of conducting health research contributes equally to the quality of the knowledge it generates as well as to its being just.

These calls for an alternate approach to research introduce necessary questions: How much is science willing to relinquish? And what is at stake if we continue with the science status quo? The heterogeneity we found in our participants’ conceptions of what CE is for and what it ought to accomplish indicates that researchers and funders of PMR hold wide-ranging ideas about their roles and obligations in relation to CE. The often ad hoc ways in which decisions about CE practices were made suggest that research teams were either less than reflective about how CE was enacted and the consequences of those choices, and/or unable to implement CE in ways that they believed were appropriate, meaningful, or ethical. And the occasional retroactive labeling of activities as CE when they were not initially defined as such both illustrates an understanding of the importance of CE but also constitutes a problematic practice that can undermine trust and short-circuit more intentional strategies for conducting it. Our findings thus reveal that while there is already some willingness to fundamentally change how PMR is done, we face a significant gap in what it will take to make this practically possible. Closing this gap requires fundamentally remaking our infrastructures that support PMR and indeed, biomedical research more generally.

PMR persistently, if not uniquely, valorizes big data that is efficiently collected and well harmonized. This understanding drives the formation of large research consortia, because they enable the amalgamation of big data and create organizational structures within which specific and different data might be reconciled, erasing the local. Recent mandates for PMR studies to reflect the diversity of the US are rooted in the argument that doing so will yield data that can be truly useful for all populations and diverse scientific needs. Yet if PMR were to continue practices of “pantomime” and check-box CE, this could deeply undermine the legitimacy of this argument. As Juengst (Citation2003, 196) points out, "to the extent that [CE] is used as a moral placebo to give the impression that ‘every effort’ is being made to protect and respect genetic populations … however well intended, it becomes a misleading, self-defeating attempt to achieve an inappropriate goal."

A choice to pursue “normal” PMR without deep CE thus risks our continued ability to include diverse populations, to forge new relationships with communities, to doing things differently. Alternatively, to realize the potential for meaningful diversity and inclusion, and for PMR to be conducted in equity-promoting ways, there must be a willingness to entertain tradeoffs between what conventionally counts as ‘scientific progress’ and CE goals that might well challenge those assumptions. That is, we argue that PMR must reimagine the goals of scientific discovery in ways that center community interests. This requires profound shifts in community engagement practices, toward approaches that share power and decisionmaking in the conduct of precision medicine research.

Acknowledgments

We are grateful to our study participants for sharing their time, perspectives, and experiences with us during observations and interviews. We also appreciate the input and collaboration of Aliya Saperstein, Caitlin McMahon, and Larissa Saco. Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under award number R01HG010330. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Disclosure statement

The authors declare that they have no conflicts of interest.

References

  • Adams, V., N. J. Burke, and I. Whitmarsh. 2014. Slow research: Thoughts for a movement in global health. Medical Anthropology 33 (3):179–97. doi: 10.1080/01459740.2013.858335.
  • Agongo, G., C. Debpuur, L. Amenga-Etego, E. A. Nonterah, M. B. Kaburise, A. Oduro, M. Ramsay, and P. Tindana. 2021. Community engagement and feedback of results in the H3Africa AWI-Gen Project: Experiences from the Navrongo Demographic and Health Surveillance site in Northern Ghana. AAS Open Research 4:15. doi: 10.12688/aasopenres.13081.1.
  • Alleva, L. 2006. Taking time to savour the rewards of slow science. Nature 443 (7109):271. doi: 10.1038/443271e.
  • Beaton, A., M. Hudson, M. Milne, R. V. Port, K. Russell, B. Smith, V. Toki, L. Uerata, P. Wilcox, K. Bartholomew, et al. 2017. Engaging Māori in biobanking and genomic research: A model for biobanks to guide culturally informed governance, operational, and community engagement activities. Genetics in Medicine 19 (3):345–51. doi: 10.1038/gim.2016.111.
  • Blacksher, E., V. Y. Hiratsuka, J. W. Blanchard, J. R. Lund, J. Reedy, J. A. Beans, B. Saunkeah, M. Peercy, C. Byars, J. Yracheta, et al. 2021. Deliberations with American Indian and Alaska Native people about the ethics of genomics: An adapted model of deliberation used with three tribal communities in the United States. AJOB Empirical Bioethics 12 (3):164–78. doi: 10.1080/23294515.2021.1925775.
  • Brunger, F., and D. Wall. 2016. What do they really mean by partnerships?" Questioning the unquestionable good in ethics guidelines promoting community engagement in Indigenous health research. Qualitative Health Research 26 (13):1862–77. doi: 10.1177/1049732316649158.
  • Burgess, M., K. O’Doherty, and D. Secko. 2008. Biobanking in British Columbia: Discussions of the future of personalized medicine through deliberative public engagement. Personalized Medicine 5 (3):285–96. doi: 10.2217/17410541.5.3.285.
  • Charmaz, K. 2014. Constructing Grounded Theory. 2nd ed. Thousand Oaks, CA: Sage.
  • Cheung, A. T. M. 2018. Including everyone but engaging no one? Partnership as a prerequisite for trustworthiness. The American Journal of Bioethics : AJOB 18 (4):55–7. doi: 10.1080/15265161.2018.1431711.
  • Cohn, E. G., M. Husamudeen, E. L. Larson, and J. K. Williams. 2015. Increasing participation in genomic research and biobanking through community-based capacity building. Journal of Genetic Counseling 24 (3):491–502. doi: 10.1007/s10897-014-9768-6.
  • Dheensa, S., G. Samuel, A. M. Lucassen, and B. Farsides. 2018. Towards a National Genomics Medicine Service: The challenges facing clinical-research hybrid practices and the case of the 100 000 Genomes Project. Journal of Medical Ethics 44 (6):397–403. doi: 10.1136/medethics-2017-104588.
  • Dry, S. M., S. B. Garrett, B. A. Koenig, A. F. Brown, M. M. Burgess, J. R. Hult, H. Longstaff, E. S. Wilcox, S. K. Madrigal Contreras, A. Martinez, et al. 2017. Community recommendations on biobank governance: Results from a deliberative community engagement in California. PloS One 12 (2):e0172582. doi: 10.1371/journal.pone.0172582.
  • Fohner, A. E., K. G. Volk, and E. L. Woodahl. 2019. Democratizing precision medicine through community engagement. Clinical Pharmacology and Therapeutics 106 (3):488–90. doi: 10.1002/cpt.1508.
  • Folayan, M. O., K. S. Oyedeji, and O. A. Fatusi. 2015. Community members’ engagement with and involvement in genomic research: Lessons to learn from the field. Developing World Bioethics 15 (1):1–7. doi: 10.1111/dewb.12020.
  • Gichuru, E., B. Kombo, N. Mumba, S. Sariola, E. J. Sanders, and E. M. van der Elst. 2018. Engaging religious leaders to support HIV prevention and care for gays, bisexual men, and other men who have sex with men in coastal Kenya. Critical Public Health 28 (3):294–305. doi: 10.1080/09581596.2018.1447647.
  • Grayson, S., M. Doerr, and J.-H. Yu. 2020. Developing pathways for community-led research with big data: A content analysis of stakeholder interviews. Health Research Policy and Systems 18 (1):76. doi: 10.1186/s12961-020-00589-7.
  • Haldeman, K. M., R. J. Cadigan, A. Davis, A. Goldenberg, G. E. Henderson, D. Lassiter, and E. Reavely. 2014. Community engagement in US biobanking: Multiplicity of meaning and method. Public Health Genomics 17 (2):84–94. doi: 10.1159/000357958.
  • Jeske, M., E. Vasquez, S. M. Fullerton, A. Saperstein, M. Bentz, N. Foti, J. K. Shim, and S. S.-J. Lee. 2022. Beyond inclusion: Enacting team equity in precision medicine research. PloS One 17 (2):e0263750. doi: 10.1371/journal.pone.0263750.
  • Juengst, E. T. 2003. Community engagement in genetic research: The ‘slow code’ of research ethics? In Populations and Genetics: Legal and Socio-Ethical Perspectives, ed. Bartha M. Knoppers, 181–97. The Netherlands: Martinus Nijhoff. http://brill.com/view/book/edcoll/9789047402930/B9789047402930_s010.xml.
  • Key, K. D., D. Furr-Holden, E. Y. Lewis, R. Cunningham, M. A. Zimmerman, V. Johnson-Lawrence, and S. Selig. 2019. The continuum of community engagement in research: A roadmap for understanding and assessing progress. Progress in Community Health Partnerships: Research, Education, and Action 13 (4):427–34. doi: 10.1353/cpr.2019.0064.
  • Lee, S. S.-J. 2021. Response to Open Peer Commentaries: Distinguishing the ‘gift’ from ‘donation’ as a path toward reciprocity and relational ethics. The American Journal of Bioethics: AJOB 21 (4):W1–W3. doi: 10.1080/15265161.2021.1905102.
  • Lemke, A. A., J. T. Wu, C. Waudby, J. Pulley, C. P. Somkin, and S. B. Trinidad. 2010. Community engagement in biobanking: Experiences from the eMERGE network. Genomics, Society and Policy 6 (3):50. doi: 10.1186/1746-5354-6-3-50.
  • Lyles, C. R., M. R. Lunn, J. Obedin-Maliver, and K. Bibbins-Domingo. 2018. The new era of precision population health: Insights for the All of Us Research Program and beyond. Journal of Translational Medicine 16 (1):4. doi: 10.1186/s12967-018-1585-5.
  • Marsh, V. M., D. M. Kamuya, A. M. Mlamba, T. N. Williams, and S. S. Molyneux. 2010. Experiences with community engagement and informed consent in a genetic cohort study of severe childhood diseases in Kenya. BMC Medical Ethics 11:13. doi: 10.1186/1472-6939-11-13.
  • Molyneux, S., and S. Bull. 2013. Consent and community engagement in diverse research contexts: Reviewing and developing research and practice: Participants in the Community Engagement and Consent Workshop, Kilifi, Kenya. Journal of Empirical Research on Human Research Ethics 8 (4):1–18. March 2011 doi: 10.1525/jer.2013.8.4.1.
  • Moodley, K. 2017. Legitimacy, trust and stakeholder engagement: Biobanking in South Africa. Asian Bioethics Review 9 (4):325–34. doi: 10.1007/s41649-017-0035-7.
  • Moodley, K., and C. Beyer. 2019. Tygerberg Research Ubuntu-Inspired Community Engagement Model: Integrating community engagement into genomic biobanking. Biopreservation and Biobanking 17 (6):613–24. doi: 10.1089/bio.2018.0136.
  • Müller, R. 2014. Racing for what? Anticipation and acceleration in the work and career practices of academic life science postdocs. Forum Qualitative Sozialforschung/Forum: Qualitative Social Research 15. doi: 10.17169/fqs-15.3.2245.
  • Murtagh, M. J., J. T. Minion, A. Turner, R. C. Wilson, M. Blell, C. Ochieng, B. Murtagh, S. Roberts, O. W. Butters, and P. R. Burton. 2017. The ECOUTER Methodology for stakeholder engagement in translational research. BMC Medical Ethics 18 (1):24. doi: 10.1186/s12910-017-0167-z.
  • Need, A. C., and D. B. Goldstein. 2009. Next generation disparities in human genomics: Concerns and remedies. Trends in Genetics 25 (11):489–94. doi: 10.1016/j.tig.2009.09.012.
  • O’Daniel, J. M., K. D. Rosanbalm, L. Boles, G. M. Tindall, T. M. Livingston, and S. B. Haga. 2012. Enhancing geneticists’ perspectives of the public through community engagement. Genetics in Medicine 14 (2):243–9. doi: 10.1038/gim.2011.29.
  • O’Daniel, J. M., S. Ackerman, L. R. Desrosiers, S. Rego, S. J. Knight, L. Mollison, G. Byfield, K. P. Anderson, M. I. Danila, C. R. Horowitz, CSER Stakeholder and Engagement Work Group, et al. 2022. Integration of stakeholder engagement from development to dissemination in genomic medicine research: Approaches and outcomes from the CSER consortium. Genetics in Medicine 24 (5):1108–19. doi: 10.1016/j.gim.2022.01.008.
  • Popejoy, A. B., and S. M. Fullerton. 2016. Genomics Is failing on diversity. Nature 538 (7624):161–4. doi: 10.1038/538161a.
  • Pratt, B., and J. de Vries. 2018. Community engagement in global health research that advances health equity. Bioethics 32 (7):454–63. doi: 10.1111/bioe.12465.
  • Pratt, B., P. Yeong Cheah, and V. Marsh. 2020. Solidarity and community engagement in global health research. The American Journal of Bioethics : AJOB 20 (5):43–56. doi: 10.1080/15265161.2020.1745930.
  • Reynolds, L., and S. Sariola. 2018. The ethics and politics of community engagement in global health research. Critical Public Health 28 (3):257–68. doi: 10.1080/09581596.2018.1449598.
  • Richardson, E. Z., S. V. Bandewar, R. F. Boulanger, R. Mehta, T. Lin, R. Vincent, S. Molyneux, A. Goldstone, and J. V. Lavery. 2021. Addressing diversity and complexity in the community engagement literature: The rationale for a realist review. Wellcome Open Research 5 (March):1. doi: 10.12688/wellcomeopenres.15525.2.
  • Sabatello, M., and P. S. Appelbaum. 2017. The precision medicine nation. The Hastings Center Report 47 (4):19–29. doi: 10.1002/hast.736.
  • Sanders Thompson, V. L., N. Ackermann, K. L. Bauer, D. J. Bowen, and M. S. Goodman. 2021. Strategies of community engagement in research: Definitions and classifications. Translational Behavioral Medicine 11 (2):441–51. doi: 10.1093/tbm/ibaa042.
  • Seeley, J. A., J. F. Kengeya-Kayondo, and D. W. Mulder. 1992. Community-based HIV/AIDS research–Whither community participation? Unsolved problems in a research programme in rural Uganda. Social Science & Medicine 34 (10):1089–95. doi: 10.1016/0277-9536(92)90282-u.
  • Tindana, P., M. Campbell, P. Marshall, K. Littler, R. Vincent, J. Seeley, J. de Vries, and D. Kamuya. 2017. Developing the science and methods of community engagement for genomic research and biobanking in Africa. Global Health, Epidemiology and Genomics 2:E13. doi: 10.1017/gheg.2017.9.
  • Tindana, P., J. de Vries, M. Campbell, K. Littler, J. Seeley, P. Marshall, J. Troyer, M. Ogundipe, V. P. Alibu, A. Yakubu, et al. 2015. Community engagement strategies for genomic studies in Africa: A review of the literature. BMC Medical Ethics 16 (1):24. doi: 10.1186/s12910-015-0014-z.
  • Tuttle, K. R., R. Knight, P. S. Appelbaum, T. Arora, S. Bansal, J. Bebiak, K. Brown, C. Campbell, L. Cooperman, C. P. Corona-Villalobos, et al. 2021. Integrating patient priorities with science by community engagement in the Kidney Precision Medicine Project. Clinical Journal of the American Society of Nephrology : CJASN 16 (4):660–8. doi: 10.2215/CJN.10270620.
  • Versfeld, A., A. Scheibe, S. Shelly, and J. Wildschut. 2018. Empathic response and no need for perfection: Reflections on harm reduction engagement in South Africa. Critical Public Health 28 (3):329–39. doi: 10.1080/09581596.2018.1443204.
  • Wilkins, C. H., and P. M. Alberti. 2019. Shifting academic health centers from a culture of community service to community engagement and integration. Academic. Academic Medicine : journal of the Association of American Medical Colleges 94 (6):763–7. doi: 10.1097/ACM.0000000000002711.
  • Wilson, W. D., F. Hall Jackson, and J. R. Harrell. 2019. Framework for Ethical Community Engagement (ECE) with underserved populations in the rural South: A help for bioethics and healthcare promotion. Journal of Health Care for the Poor and Underserved 30 (4S):91–104. doi: 10.1353/hpu.2019.0120.